Vanguard Group’s Summit Therapeutics SMMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$195M	Sell	11,177,220 -202,508	-2%	-$3.81M	﹤0.01%	1563
2025 Q3	$235M	Buy	11,379,728 +2,706,056	+31%	+$65.6M	﹤0.01%	1464
2025 Q2	$185M	Sell	8,673,672 -2,966,835	-25%	-$67.7M	﹤0.01%	1542
2025 Q1	$225M	Sell	11,640,507 -30,069	-0.3%	-$603K	﹤0.01%	1430
2024 Q4	$208M	Buy	11,670,576 +724,040	+7%	+$14M	﹤0.01%	1513
2024 Q3	$240M	Buy	10,946,536 +2,128,073	+24%	+$29.8M	﹤0.01%	1449
2024 Q2	$68.8M	Buy	8,818,463 +1,549,220	+21%	+$8.37M	﹤0.01%	2018
2024 Q1	$30.1M	Buy	7,269,243 +254,261	+4%	+$1.01M	﹤0.01%	2394
2023 Q4	$18.3M	Buy	7,014,982 +919,307	+15%	+$1.89M	﹤0.01%	2639
2023 Q3	$11.4M	Sell	6,095,675 -4,815	-0.1%	-$9.18K	﹤0.01%	2815
2023 Q2	$15.3M	Buy	6,100,490 +4,635,361	+316%	+$8.46M	﹤0.01%	2710
2023 Q1	$2.56M	Buy	1,465,129 +21,571	+1%	+$58.8K	﹤0.01%	3587
2022 Q4	$6.14M	Buy	1,443,558 +667,636	+86%	+$1.21M	﹤0.01%	3204
2022 Q3	$923K	Hold	775,922	–	–	﹤0.01%	4026
2022 Q2	$776K	Sell	775,922 -135,474	-15%	-$190K	﹤0.01%	4166
2022 Q1	$2.23M	Buy	911,396 +4,509	+0.5%	+$11.4K	﹤0.01%	3911
2021 Q4	$2.44M	Buy	906,887 +1,357	+0.1%	+$6.52K	﹤0.01%	3969
2021 Q3	$4.54M	Buy	905,530 +25,632	+3%	+$184K	﹤0.01%	3724
2021 Q2	$6.56M	Buy	879,898 +330,356	+60%	+$2.17M	﹤0.01%	3440
2021 Q1	$3.23M	Hold	549,542	–	–	﹤0.01%	3734
2020 Q4	$2.58M	Buy	+549,542	New	+$2.33M	﹤0.01%	3594